Financial statements Pharmavit
Balance sheet data of PHARMAVIT
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 095 838,70 | 962 706,04 | 848 490,66 | 724 790,31 | 762 087,31 | 931 293,48 |
| A. Fixed assets | 535 805,30 | 432 484,77 | 373 865,67 | 320 975,16 | 279 698,96 | 259 286,25 |
| B. Current assets | 560 033,40 | 530 221,27 | 474 624,99 | 403 815,15 | 482 388,35 | 672 007,23 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 1 095 838,70 | 962 706,04 | 848 490,66 | 724 790,31 | 762 087,31 | 931 293,48 |
| A. Equity | -52 680,57 | -10 967,90 | -66 467,96 | -62 060,89 | -62 063,60 | -136 668,13 |
| B. Liabilities and provisions for liabilities | 1 148 519,27 | 973 673,94 | 914 958,62 | 786 851,20 | 824 150,91 | 1 067 961,61 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | 1 124 003,45 | 938 548,17 | 861 739,59 | 753 257,47 | 775 796,67 | 1 032 376,61 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.